Baidu
map

PNAS:急性青光眼或是一种炎症性疾病

2014-07-17 佚名 生物谷

近日,中美研究人员合作发现,小鼠急性青光眼在很大程度上是一种炎症性疾病,眼部压力升高或是通过炎症反应来导致视力丧失的。这项研究发表在PNAS杂志上,这对所谓的急性闭角型青光眼的治疗具有非常重要的临床意义。研究是首次揭示了高眼压导致急性青光眼患者视力减退的炎症机制。 青光眼是指眼内压间断或持续升高的一种常见疑难眼病。青光眼是导致人类失明的三大致盲眼病之一,根据前房前角的形态及发病缓急,又分为急,慢

近日,中美研究人员合作发现,小鼠急性青光眼在很大程度上是一种炎症性疾病,眼部压力升高或是通过炎症反应来导致视力丧失的。

这项研究发表在PNAS杂志上,这对所谓的急性闭角型青光眼的治疗具有非常重要的临床意义。研究是首次揭示了高眼压导致急性青光眼患者视力减退的炎症机制。

青光眼是指眼内压间断或持续升高的一种常见疑难眼病。青光眼是导致人类失明的三大致盲眼病之一,根据前房前角的形态及发病缓急,又分为急,慢性闭角型青光眼。急性闭角型青光眼往往是一个令人痛苦的眼科急诊,患者有一个突然上升的眼压和视力的直接损伤。

在这项研究中,研究人员发现,小鼠眼内压快速,持续大幅度的增高会开启基因(TLR4),导致caspase-8蛋白的激活。反过来这个信号蛋白触发那些通常有助于哺乳动物对抗微生物感染的炎性蛋白质的生成。

免疫反应是一把双刃剑,因为在正常情况下,对抗微生物感染的炎性蛋白保护我们免受感染,但在急性青光眼的情况下,炎性反应会刺激视网膜细胞的细胞凋亡(程序性细胞死亡)。

为了进一步证实高眼压与视网膜损伤的炎性机制联系,研究人员发现:可以通过抑制TLR4基因或caspace-8蛋白,减缓急性青光眼小鼠的视网膜细胞死亡。

原始出处:


Chi W1, Li F1, Chen H1, Wang Y1, Zhu Y1, Yang X1, Zhu J2, Wu F2, Ouyang H2, Ge J1, Weinreb RN2, Zhang K3, Zhuo Y4.Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma.Proc Natl Acad Sci U S A. 2014 Jul 14. pii: 201402819. [Epub ahead of print]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1736790, encodeId=d9561e36790e9, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Sun Feb 08 14:07:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10751, encodeId=986110e5132, content=新发现,还有待证实, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bc892015, createdName=sweetai, createdTime=Wed Jul 30 22:01:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546999, encodeId=87df154699964, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Jul 19 00:07:00 CST 2014, time=2014-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855591, encodeId=6ab21855591c5, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Sun Oct 12 07:07:00 CST 2014, time=2014-10-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1736790, encodeId=d9561e36790e9, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Sun Feb 08 14:07:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10751, encodeId=986110e5132, content=新发现,还有待证实, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bc892015, createdName=sweetai, createdTime=Wed Jul 30 22:01:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546999, encodeId=87df154699964, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Jul 19 00:07:00 CST 2014, time=2014-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855591, encodeId=6ab21855591c5, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Sun Oct 12 07:07:00 CST 2014, time=2014-10-12, status=1, ipAttribution=)]
    2014-07-30 sweetai

    新发现,还有待证实

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1736790, encodeId=d9561e36790e9, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Sun Feb 08 14:07:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10751, encodeId=986110e5132, content=新发现,还有待证实, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bc892015, createdName=sweetai, createdTime=Wed Jul 30 22:01:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546999, encodeId=87df154699964, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Jul 19 00:07:00 CST 2014, time=2014-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855591, encodeId=6ab21855591c5, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Sun Oct 12 07:07:00 CST 2014, time=2014-10-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1736790, encodeId=d9561e36790e9, content=<a href='/topic/show?id=56bf6e024d4' target=_blank style='color:#2F92EE;'>#炎症性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67024, encryptionId=56bf6e024d4, topicName=炎症性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d7334182962, createdName=ms9651749636653578, createdTime=Sun Feb 08 14:07:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10751, encodeId=986110e5132, content=新发现,还有待证实, beContent=null, objectType=article, channel=null, level=null, likeNumber=155, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bc892015, createdName=sweetai, createdTime=Wed Jul 30 22:01:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546999, encodeId=87df154699964, content=<a href='/topic/show?id=4ef26e01766' target=_blank style='color:#2F92EE;'>#炎症性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67017, encryptionId=4ef26e01766, topicName=炎症性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09e813968720, createdName=12498dd9m15暂无昵称, createdTime=Sat Jul 19 00:07:00 CST 2014, time=2014-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855591, encodeId=6ab21855591c5, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Sun Oct 12 07:07:00 CST 2014, time=2014-10-12, status=1, ipAttribution=)]
    2014-10-12 drwjr
Baidu
map
Baidu
map
Baidu
map